View on Pubmed.gov 26084608 | View on doi.org 10.1007/s13277-...
HMGB1 overexpression correlates with poor prognosis in early-stage squamous cervical cancer.
- Department of Pathology, Shanxi Medical University FenYang College, 032200, Fenyang, Shanxi Province, People's Republic of China. yirongxu@163.com.
- Department of Pathology, Shanxi Medical University FenYang College, 032200, Fenyang, Shanxi Province, People's Republic of China.
- Department of Pathology, Shanxi Tumor Hospital (Shanxi Institute of Oncology), Taiyuan, Shanxi Province, China.
- Department of Pathology, Shanxi Fenyang Hospital, Fenyang, Shanxi Province, China.
Abstract
High mobility group box 1 (HMGB1) is associated with tumor progression and a poor prognosis; microtubule-associated protein 1 light chain 3 (LC3) plays a critical role in autophagy. However, the roles of HMGB1 and LC3 in squamous cervical cancer (SCC) remain unclear. An array of 166 early-stage SCC, 62 cervical intraepithelial neoplasia (CIN), and 50 normal cervical tissue samples was assessed. HMGB1 and LC3 protein levels were examined by immunohistochemistry, and the associations of HMGB1 and LC3 levels with clinicopathological characteristics evaluated, to assess their prognosis significance. High nuclear HMGB1 levels were detected in 72.9% SCC cases; 16% cases showed cytoplasmic expression of HMGB1 in cancer cells with low nuclear expression. Interestingly, HMGB1 levels in SCC samples were significantly higher than CIN and control specimens, while lower LC3 expression was found in SCC samples (P < 0.001). Nuclear HMGB1 expression was weakly negatively correlated to LC3 amounts (r = -0.254, P = 0.001). High nuclear HMGB1 levels were associated with vascular metastasis (P < 0.05). In addition, cytoplasmic HMGB1 expression was associated with lymph node metastasis (P < 0.05). Furthermore, high nuclear HMGB1 levels and cytoplasmic HMGB1 expression predicted poor overall survival (OS) and disease-free survival (DFS). Meanwhile, high LC3 expression was associated with favorable prognosis. Multivariate analysis showed that both nuclear and cytoplasmic HMGB1 expressions were independent prognostic factors for overall- and disease-free survival, along with nodule metastasis. HMGB1 overexpression plays a significant role in SCC progression. Both nuclear and cytoplasmic HMGB1 are independent factors for poor prognosis in early-stage SCC.
References
Methods Cell Biol. 1977;16:257-67
Cell Metab. 2014 Mar 4;19(3):539-47
Cell. 2005 Jan 28;120(2):237-48
Oncol Rep. 2009 Sep;22(3):535-9
Cited by 16 citations (total)
Journal Article Review
HMGB1 in Radiotherapy: A Two Headed Signal Regulating Tumor Radiosensitivity and Immunity.
Electronic publication date August 9, 2020
Yin Liao [...] Jingbo Wu et al.
Radiotherapy (RT) is a mainstay of cancer treatment. Recent studies have shown that RT not only directly induces cell death...
Journal Article Meta-Analysis Research Support, Non-U.S. Gov't
No association between HMGB1 polymorphisms and cancer risk: evidence from a meta-analysis.
Electronic publication date June 25, 2019
Xing-Yan Li [...] Jin-Min Zhao et al.
The aim of the present study was to determine whether High mobility group box 1 (HMGB1) polymorphism was associated with...
Conflict of interest statement
MeSH
- •
- •
- •
- •
- •
- •
- •
- •
Specialties
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
Substances
- •
- •
- •
- •